SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026909
Filing Date
2022-11-10
Accepted
2022-11-10 16:15:50
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbla20220930_10q.htm   iXBRL 10-Q 799166
2 EXHIBIT 31.1 ex_443241.htm EX-31.1 12689
3 EXHIBIT 31.2 ex_443242.htm EX-31.2 12682
4 EXHIBIT 32.1 ex_443243.htm EX-32.1 4929
5 EXHIBIT 32.2 ex_443244.htm EX-32.2 5184
  Complete submission text file 0001437749-22-026909.txt   3852801

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbla-20220930.xsd EX-101.SCH 40769
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20220930_cal.xml EX-101.CAL 23869
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20220930_def.xml EX-101.DEF 274495
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20220930_lab.xml EX-101.LAB 239747
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20220930_pre.xml EX-101.PRE 292624
49 EXTRACTED XBRL INSTANCE DOCUMENT pbla20220930_10q_htm.xml XML 457037
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 221377410
SIC: 2834 Pharmaceutical Preparations